To include your compound in the COVID-19 Resource Center, submit it here.

Eli Lilly pharmaceuticals news

Eli Lilly outlined plans to drive growth through its impending patent cliff. The strategy includes increasing the number of late-stage candidates, continuing cost reductions and expanding further into emerging markets. The pharma noted that patent expirations affecting psychiatric

Read the full 389 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers